SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-16-099994
Filing Date
2016-05-09
Accepted
2016-05-09 17:17:50
Documents
2
Group Members
FBIO ACQUISITION, INC.LINDSAY A. ROSENWALD, M.D.MICHAEL S. WEISSOPUS POINT PARTNERS MANAGEMENT, LLCOPUS POINT PARTNERS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D v439241_sc13d.htm SC 13D 155158
2 EXHIBIT 1 v439241_ex99-1.htm EX-99.1 13578
  Complete submission text file 0001144204-16-099994.txt   170760
Mailing Address 410 PARK AVENUE 14TH FLOOR NEW YORK NY 10022
Business Address 410 PARK AVENUE 14TH FLOOR NEW YORK NY 10022 212-417-8000
NATIONAL HOLDINGS CORP (Subject) CIK: 0001023844 (see all company filings)

IRS No.: 364128138 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-51125 | Film No.: 161632724
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500
Fortress Biotech, Inc. (Filed by) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations